Networking is crucial in order to make advances in the field of personalised medicine. Denmark’s biotechnology cluster highlights the importance of communication between scientists in labs, researchers in industry, and clinicians in hospitals.
Personalised medicine means giving the right medicine in the right dosage to the right patient at the right time, and research involves developing methods to diagnose and stratify patient populations to allow for targeted treatment modified to the genetic and disease profile. Where traditional medicine is based on the identification of symptoms and their treatment with a given medication, personalised medicine, conversely, is based on the fact that each patient’s symptoms can differ according to the individual’s hereditary endowment, cell division, metabolism profile and so on. Thus personalised medicine comprises individual diagnosis, allowing a stratification of patients, and resulting in an independently modified treatment.